Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.
Leila HusseiniJakob JungNatalie BoessNiels KruseStefan NesslerChristine StadelmannImke MetzMichael HauptsMartin S WeberPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
These findings highlight that measurement of sNfL levels represents a useful tool to assess the extent of neuroaxonal damage as a surrogate for clinical progression in patients with SP-MS, when age and disease activity as major confounders are taken into account.